Phenylboronic acid functionalized resveratrol-based nanomedicines with enhanced targeting for synergistic chemo-photothermal breast cancer therapy

Journal of Materials Chemistry B 2026

View at publisher
Authors: Qirui Bi, Danni Liu, Yunfei Tan, Pengyu Hu, Qiulan Tong, Lei Ma, Jianming Jiang, Xudong Li, Zeng Yi
DOI: 10.1039/d5tb02941d
Cited by: 0
References: 38

Abstract

antitumor studies revealed that RevDI NPs achieved a tumor inhibition rate of 87.5% under synergistic chemo-photothermal treatment, without inducing observable toxicity in major organs. Overall, this work highlights PBA-functionalized Res-based nanomedicines as an effective platform for targeted and synergistic cancer therapy, offering potential for further translational development.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Nanoparticle-Based Drug Delivery Photodynamic Therapy Research Studies

Publication details

Journal / source
Journal of Materials Chemistry B
Volume
14
Issue
10
Pages
3239–3254
Publication date
1 January 2026
Language
EN